Bruce Goodwin
Bruce has four decades working in Lifesciences and is currently a Non-executive Director of five organisations, all operating in the healthcare sector. His past experience includes 37 years in the Global Biopharmaceutical industry, having previously been employed by the Janssen Pharmaceutical Companies of Johnson & Johnson. Bruce’s employment with Janssen included large/multi country leadership roles, resulting in significant organisational success. He is a respected industry leader with more than a decade of experience at the Board level in industry peak bodies in Australia and Japan.
Craig Jones
Craig is an operating partner to emerging enterprise technology companies, helping them to reach their global potential. As a board member and investor, he has leveraged a successful track record in global field operations, product and market innovation in industrial software, to guide the acquisition of AgilityCIS, Pegasus, Prometheus Group, Optimatics and Sage Technology. He was previously an Operating Advisor with global technology investment firm Francisco Partners, and has held senior executive roles at ABB Enterprise Software, Mincom, Oracle and Descartes Systems Group.
Bill Bartee
Bill is General Partner of CSIRO’s venture fund, Main Sequence Ventures. He was co-founder of both Blackbird Ventures and Southern Cross Venture Partners. Bill helped build and lead the early stage investing for Macquarie Technology Ventures (MTV) and has co-founded several successful companies.
Eric Chung
As a co-founder of Prospection, Eric has built a business fueled by deep understanding of the life sciences industry. He has become a leading thinker around innovative ways to process real world data and the use of patient-level data for powering better business decisions and helping patients achieve better health outcomes. Eric brings 20 years of insights from business consulting with Accenture, start-up creation and management, and data and analytics across multiple industries.
Dr Peter Cronin
Cancer patient at 21, medical doctor at 30, successful first healthcare start-up and exit by 36. Dr. Peter Cronin brings a wealth of technical knowledge to Prospection with his qualifications in medicine, business, and technology, as well as over 20 years’ experience working in clinical practices and successful healthcare business building.
Jayne Shaw
From Director of Nursing and Chief Executive Officer of two private hospitals. Jayne built and sold a consulting business and went on to co-found Vision Group an Opthalmic Doctor equity consolidation model which was successfully listed on the ASX. Joining a number of private Healthcare Boards involved with specialist consolidation including Cardiology, Orthopaedics, and Women’s Health she continued to work with Private Equity firms on local and International Healthcare transactions. Jayne, together with Ron Phillips was a co-owner of Sydney Breast Clinic and a co-founder of BCAL Diagnostics. Current Board positions are Critical Group – Heatley’s Industrial Supplies, The Woolcock Research Institute, and The Hareda Foundation established to invest in Women’s Health Initiatives.
Chris Liu
Chris Liu is an investor with Horizons Ventures interested in technologies that have the potential to disrupt massive incumbent industries. He was previously the Director of User Experience at Intel. Prior to Intel, he led the transformation and exponential growth of Fjord, an innovation consulting firm acquired by Accenture in 2013, and as the Head of the Interface Design Group for EMEA at Sony between 2003 – 2007.
